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Abstract Three transmembrane aspartyl residues play essential 
roles in the transposon Tnl0-encoded metal-tetracycline/H + 
antiporter (Tet(B)) IYamaguchi, A. et al. (1992) J. Biol. Chem. 
267, 7490-7498]. The tetK gene-encoding tetracycline resistance 
protein (Tet(K)) of Staphylococcus aureus mediates metal- 
tetracycline/H +antiport similarly to Tet(B); however, it has no 
transmembrane aspartyl residue. On the other hand, Tet(K) has 
three glutamyl residues, Glu-30, Glu-152 and Glu-397, in the 
putative transmembrane r gions. In the present work, tet(K) gene 
was expressed in Escherichia coli and the transport activity was 
measured in everted membrane vesicles. When these glutamyl 
residues were replaced with Gin, the tetracycline transport 
activity was almost completely lost, indicating the important 
roles of these residues in Tet(K). In the case of Glu-397, even the 
charge-conserved mutation to Asp caused complete loss of the 
activity. On the other hand, the mutation of Glu-30 and Glu-152 
to Asp resulted in significant retention of transport activity. 
These results are similar to those on the mutation of the three 
transmemhrane aspartyl residues in Tet(B), indicating that the 
transmembrane glutamyl residues in Tet(K) play roles similar to 
those of the transmemhrane aspartyl residues in Tet(B). 
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I. Introduction 
The tet(K) gene is responsible for tetracycline resistance of 
Staphylococcus aureus [2,3] as well as the tet(M) gene which 
encodes the ribosomal protection system [4,5]. The Tet(K) 
protein is closely related to the Tet(L) protein found among 
Gram-positive pathogens [6-8]. They confer resistance by the 
active efttux of tetracycline. The substrate transported by 
Tet(K) is a tetracycline-divalent-cation chelation complex 
[9]. The drug efltux is driven by an antiport with protons. 
These mechanisms are very similar to those of the Tet proteins 
of Gram-negative enteric bacteria [10]. In Gram-negative bac- 
teria, tetracycline resistance is mostly assigned to the drug 
etitux systems, which are classified into A-H [11]. They have 
a conserved sequence motif, G(K/R)XSD(R/K)XGR(R/K), in 
the first cytoplasmic loop (named loop2-3), which is common 
not only in bacterial drug export proteins [12,13] but also in 
the secondary transporters and belongs to a major facilitator 
family [14,15]. Tet(K) and Tet(L) also contain a derivative of 
this motif, GKXSDXX(X/G)XK(K/R), in the corresponding 
loop, indicating that they belong to a major facilitator family. 
*Corresponding author. 
**Present address: Exploratory Research Laboratories, Tukuba 
Research Institute, Banyu Pharmaceutical Co., Ltd. Tsukuba Tech- 
no-Park Oho, Okubo 3, Tukuba 300-33, Japan. 
In spite of such similarity in the function and sequence 
motif between Tet proteins of Gram-positive and Gram-nega- 
tive microorganisms, there are large apparent differences in 
their molecular features. Tet(B) and Tet(C), which are well- 
studied Tet proteins in Gram-negative bacteria [16], are inte- 
gral membrane proteins of about 43 kDa which consist of 12 
membrane-spanning segments with a large central loop 
[17,18]. On the other hand, the molecular sizes of Tet(K) 
and Tet(L) are greater than those of Tet(B) and Tet(C). On 
the basis of hydropathy analysis and the odd-number-span- 
ning rule of membrane transporters, Guay et al. [19] predicted 
that Tet(K) contains 14 transmembrane h lices. However, 
there is no distinct hydrophilic region between hydrophobic 
segments 7 and 8. Thus, an alternative topology is possible, 
with Tet(K) consisting of 12-transmembrane segments with a 
large central oop (Fig. 1). The long hydrophobic part of the 
central loop may form a-helices partially embedded in the 
membrane locus but not passing through the membrane 
(Fig. 1). 
The most striking difference between the Tet proteins of 
Gram-positive and Gram-negative bacteria is the absence of 
aspartic acid in the putative transmembrane region of Tet(K) 
and Tet(L) (Fig. 1). In the Tet proteins of enteric bacteria, the 
three aspartic acid residues are conserved in their membrane- 
spanning regions and play essential roles for tetracycline bind- 
ing [20] and translocation across the membrane [1], probably 
through ionic interaction with the positively charged metal- 
tetracycline chelation complex. These three aspartic acid resi- 
dues are located in the putative transmembrane h lices 1, 3, 
and 9 [1]. On the other hand, three glutamic acid residues are 
conserved in the transmembrane regions of Tet(K) and Tet(L) 
(Fig. 1). These three glutamic acid residues in Tet (K) are Glu- 
30, Glu-152 and Glu-397, which are located in transmembrane 
segments I, V and XI, respectively (Fig. 1). In this study, we 
constructed site-directed mutants in which these three gluta- 
mic acid residues were replaced in turn with a glutamine or 
aspartic acid residue. The results indicated that the glutamic 
acid residues in Tet(K) play similar roles to the essential as- 
partic acid residues in Tet(B). 
2. Materials and methods 
2.1. Materials 
[7-aH(N)]Tetracycline was purchased from Du Pont-New England 
Nuclear. All other chemicals were of reagent grade and obtained from 
commercial sorces. 
2.2. Bacterial strains and plasmids 
E. coli W3104 [21] was used as the host strain expressing the tet(K) 
gene and for the preparation of inverted membrane vesicles, pTZ1252, 
which was a gift from N. Noguchi, Tokyo College of Pharmacy, was 
constructed by insertion of a 2.3 kb HindlII fragment of pNS1, which 
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carries the tet(K) gene of S. aureus [3], into pUCll9, in which the 
initiation codon and the ribosome binding sequence (RBS) were 
changed from TTG to ATG and from GAGG to GGAGG, respec- 
tively, and the distance between the RBS and the initiation codon was 
altered from 4 to 11 bases [22]. pUC118RV [1] was constructed from 
pUC118 [23] by changing the SacI site to an EcoRV site. pTKN1 and 
pTKC2 are the plasmids constructed by subcloning of the 5'- and 3'- 
halves of the tet(K) gene, respectively, into pUC118 and pUC118RV, 
respectively, pTKN1 was constructed by insertion of the EcoRI-KpnI 
fragment of pTZ1252 into the corresponding cloning site of pUC118. 
pTKC2 was constructed by insertion of the HindlII-EcoRV fragment 
of pTZ1252 into the corresponding cloning site of pUC118RV. 
2.3. Site-directed mutagenesis 
Mutagenesis at codons 30 and 152, and at codon 397 in the tet(K) 
gene was performed using pTKN1 and pTKC2, respectively, as a 
template. The method employed for mutagenesis was mainly that of 
Kunkel [24], however, for mutagenesis atcodon 152, we employed the 
procedure of Taylor et al. [25]. The mutagenic primers used were as 
follows: E30Q, 5'-ATTAAATCAAATGGTCCTAAATG-3'; E30D, 
5'-TTAAATGA__CATGGTCCTAAATG*3'; E152Q, 5'-CTTTAGG- 
CCAAGGGTT-3'; E152D, 5'-TTAGGTGACGGCCTAGGTCCT- 
TC-3'; E397Q, 5'-TTTATCCCAAGGAACA-3'; E397D, 5'-TTAT- 
CAGACGGTACCGGTATAGC-3'. In the above oligonucleotide 
sequences, the underlined letters indicate the mismatched bases which 
generate the replacement of amino acid residues or the new restriction 
sites without amino acid change. The mutation was first detected by 
restriction analysis and then confirmed by DNA sequencing. The mu- 
tant tet(K) gene was reconstructed from the mutant pTKN1 or 
pTKC2 by the corresponding fragment exchange with pTZ1252. 
2.4. Preparation of inverted membrane v sicles and transport assay 
Inverted membrane vesicles were prepared from E. coli W3104 har- 
boring pTZ1252 or the mutant plasmid as described in our previous 
paper [9]. Respiration-driven [3H]tetracycline uptake by inverted 
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membrane vesicles were measured in the presence of 10 I.tM 
[3H]tetracycline and 50 IxM COC12 as described in [9]. 
3. Resu l ts  and d iscuss ion 
3.1. Distribution of conserved acidic residues and putative 
topology of the Tet(K) protein 
There are 9 acidic residues conserved throughout he se- 
quences of Tet(K) and Tet(L) proteins isolated from six dif- 
ferent bacterial species [26]. The distribution of these acidic 
residues is shown in Fig. 1. Among them, Asp-200 is con- 
served except for Tet(L) encoded by pSTE1, in which Asp is 
replaced by Gly [26]. The Tet(L) protein encoded by a chro- 
mosome of B. subtilis has Asp-345 in place of Glu-345 [26]. 
The other 7 acidic residues are completely conserved in all of 
the Tet(K) and Tet(L) proteins [26]. The conserved aspartic 
acid residues are Asp-39, Asp-74, Asp-200, and Asp-318. Out 
of these aspartyl residues, Asp-74 and Asp-318 are located in 
the first and second conserved sequence motifs, respectively, 
common to the major facilitator family [27], thus, these two 
aspartic acid residues are likely to be located in the cytoplas- 
mic surface. Asp-39 and Asp-200 are located in the middle or 
the edge of the large distinct hydrophilic domains; thus, it is 
not likely that these aspartyl residues are embedded in the 
membrane. Therefore, there is no candidate for the transmem- 
brane aspartyl residues in the putative topology of Tet(K) in 
either the 14- or 12-transmembrane structure. 
There are 5 conserved glutamic acid residues, Glu-30, Glu- 
152, Glu-345, Glu-381, and Glu-397. Out of these residues, 
only Glu-381 is located in the middle of the large hydrophilic 
M-NH 2 
F 
S 
L 
Y 
K 
K 
F 74 D y 
K S - -  I 
G L N 
L K I 
F y G K 
I S l I  Y I~ILK L 
!i" ! 
^_ G T 
I v L I S 
FS S F LT FM 
L V A Y T 
30[~ N V N 
M~V ~/ N T 
N V ~ pG 
S T H 
L T N 
N H P F F 39DIA NH F 
cytoplasm 
R 
T 
I 
N 
IV R 
A 
vV~ 
L [ 
SAF P 
G SA 
V V QG 
L 
R 
G 
F 
I L 
K K O 
V F 
I FG G 
, S 
V' .  A 
Qlg2~ 
~ LG t-~ 
a p 
IIS G G 
R V S N p F 
S I 
, i I  N 
I, . K V I TL I FTw YN F N TI L 
2°°DII QL s c F'"lcI a 
T: I I tM IFT  N K , 
V V S I M L 
I 
G KTSKG 
P 
K V 
A M V 
Vl  K 
L I 
F 
I P 
T V 
i T  I 
pM 
LLL  I 
Y W S ' 
A H H y I 
318- -  
vDRK 
P L G 
F F S 
Yl l  M VI I IG IX  L 
ssSLS  
V 
I 
K 
S 
I 
V 
T 
XK  
' G= - GYF  G 
~G Sr  V F 
. I V 
. ~ M S 
AV :~ T G 
~ F P 
, ~ N SV 
, ,M~ G 
Y T 
M A 
M V 
N 
K 
T V 
I yH  
v F ' 
F L I I  FT  S L 
sG L I GG M 
I S j 
tS i  I FVF  
S F M 
, T T 
F V i F SM 
34SE 
periplasm 
E 
E E-COOH 
381E F 
V Q 
A K 
8 E 
L S 
L R 
XI N XII K 
L s l l  , T 
397 L L- 
r G~ I} L C C 
A I GI[I I. L i 
Q Gv I1 '  M A 
LL I !  A 
L N 
I $ 
N Y 
R V 
K G 
L 8 
V 
L 8 
E Y F I N 
Fig. 1. Putative 12-transmembrane domain structure of the Tet(K) protein. The hydrophobic segments are enclosed in boxes. Roman numerals 
indicate the putative transmembrane s gments. CI and CII are the predicted central hydrophobic segments not spanning the membrane but 
probably being folded in the protein interior or buried in the membrane. The conserved acidic residues in the transmembrane regions and the 
hydrophilic loop regions are indicated by shadowed and bold letters, respectively. 
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Fig. 2. Tetracycline uptake by everted membrane vesicles prepared 
from E. coli W3104 cells harboring pTZ1252 or a mutant plasmid: 
(A) pTZ1252, (B) pTZE30Q, (C)pTZE30D, (D) pTZE152Q, (E) 
pTZE152D, (F) pTZE397Q, (G) pTZE397D. Closed and open cir- 
cles indicate the uptake by the vesicles in the presence or absence of 
NADH as an energy source, respectively. 
loop, indicating localization in the water-extruding loop. The 
other four glutamic acid residues are located in the middle of 
the hydrophobic domains. Glu-30, Glu-152, and Glu-397 are 
located in the hydrophobic segments composed of about 20 
amino acid residues ufficient o span once across the mem- 
brane, whereas Glu-345 is located at the center of a large 
hydrophobic segment containing about 43 amino acid residues 
enough to span twice across the membrane. In the cases of 
Tet(B) and Tet(C), evidence has been obtained that the 3- 
membered short loop containing a glutamic acid residue be- 
tween the transmembrane s gments IX and X is located on 
the periplasmic surface ([18]; our unpublished observation). 
Glu-345 in Tet(K) is exactly located in the loop between the 
transmembrane segments IX and X in the 12-membrane-span- 
ning structure (Fig. 1). Thus, it is likely that Glu-345 is a 
member of the periplasmic short loop. Therefore, the acidic 
245 
residues clearly located in the transmembrane s gments of 
Tet(K) are Glu-30, Glu-152 and Glu-397. 
3.2. Effect of mutations in membrane-embedded glutamic acid 
residues 
Firstly, the three membrane-embedded glutamic acid resi- 
dues were replaced one by one with a glutamine residue. As 
shown in Fig. 2, all the mutants howed a large decrease in 
tetracycline transport activity. Among them, the Glu-397'Gln 
(E397Q) mutant completely lost activity (Fig. 2F). The Glu- 
30'Gln (E30Q) and Glu-152'Gln (E152Q) mutants retained 
less than 5 and 1%, respectively, of the wild-type transport 
activity (Fig. 2B,D). Therefore, it seems that Glu-30 and Glu- 
152 are very important and that Glu-397 is essential for the 
tetracycline transport function of Tet(K). 
These glutamic acid residues were then replaced by a 
charge-conserved aspartyl residue. When Glu-30 and Glu- 
152 were replaced by Asp, the resulting E30D and E152D 
mutants retained about two-thirds and one-third of the 
wild-type activity, respectively (Fig. 2C,E), indicating that 
the aspartyl side chain works more or less well in place of a 
glutamyl side chain at these positions. In contrast, when Glu- 
397 was replaced by Asp, the transport activity was comple- 
tely lost (Fig. 2G), as with the D397Q mutant. Thus, the strict 
configuration of a carboxyl group at position 397 is necessary 
for the transport function. 
In comparison with the site-directed mutants of the trans- 
membrane aspartyl residues in Tet(B) [1], the results of the 
mutagenesis of Glu-30 and Glu-152 were similar to those of 
Asp-15 and Asp-84 in Tet(B). At these positions, a negatively 
charged side-chain is necessary and the aspartyl and glutamyl 
side chains are interchangeable with each other. The result of 
the mutagenesis of Glu-397 in Tet(K) corresponds to that of 
Asp-285 in Tet(B) [1]. That is, even charge-conserved muta- 
tions at these positions resulted in the almost complete loss of 
transport activity, indicating the requirement for a particular 
configuration of the carboxyl group. Glu-30 and Glu-152 are 
located in the N-terminal half of Tet(K) as well as Asp-15 and 
Asp-84 in Tet(B). On the other hand, Glu-397 is located in the 
C-terminal half of Tet(K), as is Asp-285 in Tet(B). The loca- 
tion of Glu-30 in Tet(K) exactly corresponds to that of Asp- 
15 in Tet(B). The two residues are in the middle of the puta- 
tive transmembrane h lix I. On the other hand, the locations 
of Glu-152 and Glu-397 are different from those of Asp-84 
and Asp-285. The latter are in transmembrane h lices III and 
IX, respectively, the former being in transmembrane h lices V 
and XI, respectively, in the putative 12-transmembrane struc- 
ture (Fig. 1). However, there is an important similarity in their 
distribution. That is, both Glu-152 and Glu-397 are located in 
the 5th transmembrane helices in the N- and C-terminal 
halves, respectively, in the 12-transmembrane structure of 
Tet(K) (Fig. 1), as well as Asp-84 and Asp-285 being located 
in the 3rd transmembrane h lices in the N- and C-terminal 
halves of Tet(B), respectively. Such a symmetrical distribution 
of the functionally important residues and the correspondence 
of the mutational effects between Tet(K) and Tet(B) suggest 
that the roles of the N- and C-terminal halves of Tet(K) in 
the transport function are in consistent with those of the N- 
and C-terminal halves of Tet(B), respectively. 
Our current observation revealed that the transmembrane 
glutamic acid residues in Tet(K) play roles similar to those of 
the transmembrane aspartic acid residues in Tet(B). The mu- 
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tational correspondence shown in this manuscript confirms 
the fundamental similarity in the molecular mechanisms be- 
tween Tet(K) and Tet(B) as described in our previous paper 
[9]. 
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